{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:32:09Z","timestamp":1782480729546,"version":"3.54.5"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Treatment of steroid-resistant nephrotic syndrome (SRNS) remains a challenge for paediatricians. SRNS accounts for 10~20% of childhood cases of nephrotic syndrome (NS). Individuals with SRNS overwhelmingly progress to chronic kidney disease (CKD) and end-stage kidney disease (ESRD). Genetic research is of great significance for diagnosis and treatment. More than 39 recessive or dominant genes have been found to cause human SRNS, including <jats:italic>COQ2<\/jats:italic>. <jats:italic>COQ2<\/jats:italic> gene mutations not only cause primary coenzyme Q10 deficiency but also cause SRNS without extrarenal manifestations. The concept of <jats:italic>COQ2<\/jats:italic> nephropathy has been proposed for a long time. Mutations in the <jats:italic>COQ2<\/jats:italic> gene have rarely been reported. Worldwide, only 5 cases involving 4 families have been reported.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We present the case of a 6-month-old girl with steroid-resistant glomerulopathy due to a <jats:italic>COQ2<\/jats:italic> defect with no additional systemic symptoms. The patient was identified as a homozygote for the c.832\u2009T\u2009&gt;\u2009C (p. Cys278Arg) missense mutation and a single base homozygous mutation in <jats:italic>ARSB<\/jats:italic> gene in c.1213\u2009+\u20091G\u2009&gt;\u2009A. The father and mother were heterozygous mutation carriers in both <jats:italic>COQ2<\/jats:italic> and <jats:italic>ARSB<\/jats:italic>, and her healthy sister was only a heterozygous mutation carrier in <jats:italic>COQ2<\/jats:italic>. In this case, hormone therapy was ineffective, and progressive deterioration of renal function occurred within 1\u2009week after onset, leading to acute renal failure and eventual death.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We reported a consanguinity married family which had <jats:italic>COQ2<\/jats:italic> and <jats:italic>ARSB<\/jats:italic> dual mutant. Kidney diseases caused by <jats:italic>COQ2<\/jats:italic> gene mutations can manifest as SRNS, with poor prognosis. The C. 832\u2009T\u2009&gt;\u2009c (p.csc 278arg) is a new mutation site. Genetic assessment for children with steroid-resistant nephrotic syndrome, especially in infancy, is very important. Families with a clear family history should receive genetic counselling and prenatal examinations, and children without a family phenotype should also receive genetic screening as early as possible.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12881-019-0898-4","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T11:09:06Z","timestamp":1572260946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A steroid-resistant nephrotic syndrome in an infant resulting from a consanguineous marriage with COQ2 and ARSB gene mutations: a case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Xia","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7061-8119","authenticated-orcid":false,"given":"Wenhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linsheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,28]]},"reference":[{"key":"898_CR1","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00467-010-1495-0","volume":"25","author":"G Benoit","year":"2010","unstructured":"Benoit G, Machuca E, Antignac C. Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations. Pediatr Nephrol. 2010;25:1621\u201332. \n                    https:\/\/doi.org\/10.1007\/s00467-010-1495-0\n                    \n                  .","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"898_CR2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00467-012-2310-x","volume":"28","author":"RM Lombel","year":"2013","unstructured":"Lombel RM, Hodson EM, Gipson DS, et al. Treatment of steroid-resistant nephrotic syndrome in children:new guidelines from KDIGO. Pediatr Nephrol. 2013;28(3):409\u201314. \n                    https:\/\/doi.org\/10.1007\/s00467-012-2310-x\n                    \n                  .","journal-title":"Pediatr Nephrol"},{"key":"898_CR3","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1093\/ndt\/gfv355","volume":"31","author":"S Lovric","year":"2016","unstructured":"Lovric S, Ashraf S, Tan W, Hildebrandt F. Genetic testing in steroid-resistant nephrotic syndrome: when and how? Nephrol Dial Transplant. 2016;31:1802\u201313. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfv355\n                    \n                  .","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"898_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2215\/CJN.04120417","volume":"13","author":"JK Warejko","year":"2018","unstructured":"Warejko JK, Tan W, Daga, et al. Clin J Am Soc Nephrol. 2018;13(1):53\u201362. \n                    https:\/\/doi.org\/10.2215\/CJN.04120417\n                    \n                  .","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3\u20134","key":"898_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/ 000362826","volume":"5","author":"M Doimo","year":"2014","unstructured":"Doimo M, Desbats MA, Cerqua C, et al. genetics of coenzyme Q 10 deficiency. Mol Syndromol. 2014;5(3\u20134):156\u201362. \n                    https:\/\/doi.org\/10.1159\/000362826\n                    \n                  .","journal-title":"Mol Syndromol"},{"issue":"9","key":"898_CR6","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1681\/ASN.2016060626","volume":"28","author":"JY Zhu","year":"2017","unstructured":"Zhu JY, Fu Y, Richman A, et al. A Personalized Model of COQ2 Nephropathy Rescued by the Wild-Type COQ2 Allele or DietaryCoenzyme Q10 Supplementation. J Am Soc Nephrol. 2017;28(9):2607\u201317. \n                    https:\/\/doi.org\/10.1681\/ASN.2016060626\n                    \n                  .","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"898_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2215\/CJN.07200712","volume":"8","author":"HJ McCarthy","year":"2013","unstructured":"McCarthy HJ, Bierzynska A, Wherlock M, et al. Simultaneous sequencing of 24 genes associated with steroid-resistant nephrotic syndr-ome. Clin J Am Soc Nephrol. 2013;8(4):637\u201348. \n                    https:\/\/doi.org\/10.2215\/CJN.07200712\n                    \n                  .","journal-title":"Clin J Am Soc Nephrol"},{"issue":"19","key":"898_CR8","doi-asserted-by":"publisher","first-page":"4256","DOI":"10.1093\/hmg\/ddw257","volume":"25","author":"MA Desbats","year":"2016","unstructured":"Desbats MA, Morbidoni V, Silic-Benussi M, et al. The COQ2 genotype predicts the severity of coenzymeQ10 deficiency. Hum Mol Genet. 2016;25(19):4256\u201365. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddw257\n                    \n                  .","journal-title":"Hum Mol Genet"},{"issue":"10","key":"898_CR9","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1681\/ASN.2006080833","volume":"18","author":"F Diomedi-Camassei","year":"2007","unstructured":"Diomedi-Camassei F, Di Giandomenico S, Santorelli FM, et al. COQ2 nephropathy:a newly described inherited mitochondriopathy with primary renalinvolvement. J Am Soc Nephrol. 2007;18(10):2773\u201380. \n                    https:\/\/doi.org\/10.1681\/ASN.2006080833\n                    \n                  .","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"898_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1590\/S1415-47572010005000093","volume":"33","author":"R Giugliani","year":"2010","unstructured":"Giugliani R, Federhen A, Rojas MV. Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment. Genet Mol Biol. 2010;33(4):589\u2013604. \n                    https:\/\/doi.org\/10.1590\/S1415-47572010005000093\n                    \n                  .","journal-title":"Genet Mol Biol"},{"issue":"1","key":"898_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12687-017-0329-1","volume":"9","author":"NA Al-Sannaa","year":"2018","unstructured":"Al-Sannaa NA, Al-Abdulwahed HY, Al-Majed SI, et al. The clinical and genetic Spectrum of Maroteaux-Lamy syndrome (Mucopolysa cchaidosis VI) in the Eastern Province of Saudi Arabia. J Community Genet. 2018;9(1):65\u201370. \n                    https:\/\/doi.org\/10.1007\/s12687-017-0329-1\n                    \n                  .","journal-title":"J Community Genet"},{"issue":"9","key":"898_CR12","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1038\/ejhg.2014.277","volume":"23","author":"MA Desbats","year":"2015","unstructured":"Desbats MA, Vetro A, Limongelli I, et al. Primary coenzymeQ10 deficiency presenting as fatal neonatal multiorgan failure. Eur J Hum Genet. 2015;23(9):1254\u20138. \n                    https:\/\/doi.org\/10.1038\/ejhg.2014.277\n                    \n                  .","journal-title":"Eur J Hum Genet"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-019-0898-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12881-019-0898-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-019-0898-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:21:49Z","timestamp":1603758109000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/s12881-019-0898-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,28]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["898"],"URL":"https:\/\/doi.org\/10.1186\/s12881-019-0898-4","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,28]]},"assertion":[{"value":"11 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Tianjin Children\u2019s Hospital ethics committee approved this study (approval no.2016021). This study obtained the informed consent from the family members of the children.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s legal guardian for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"165"}}